News & Events: Flavio Vincenti, M.D.

UCSF News reports on a clinical trial, BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial) where for the first time, an immunosuppressive agent,  Belatacept, showed better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care. The study was reported on in the January 28th issue of the New England Journal of Medicine by lead author, Flavio Vincenti, MD, Clinical Professor of Medicine and Surgery in the Departments of Medicine and Surgery, and other researchers. For the first time, an [...]

The Contra Costa Times reports on the heartrending story of Chris Schroeder (pictured center), who received a donated kidney at age 50 from his wife, and then eight years later after the transplant failed, a second donated kidney from his son. Mr. Schroeder underwent successful surgery at UCSF Medical Center in December 2014 to have the transplanted kidney implanted. His UCSF nephrologist, Flavio Vincenti, M.D.  said the rejection of the first kidney was "somewhat uncommon," and had been complicated by a rare disease "C1q nephropathy" that attacked his remaining kidney. WALNUT CREEK -- [...]